出品公司: | Invivogen |
---|---|
載體名稱: | pFUSE-hIgG1e2-Fc2 |
載體又名: | pFUSE-hIgG1e2-Fc2載體,pFUSE-hIgG1e2-Fc2質粒,pFUSE-hIgG1e2-Fc2載體質粒 |
英文名稱: | pFUSE-hIgG1e2-Fc2, pFUSE-hIgG1e2-Fc2 Vector, pFUSE-hIgG1e2-Fc2 Plasmid |
質粒類型: | 哺乳動物細胞表達載體 |
高拷貝/低拷貝: | 高拷貝 |
克隆方法: | 限制性內切酶,多克隆位點 |
啟動子: | CMV |
載體大小: | 4.2 kb |
5’測序引物: | -- |
3’測序引物: | -- |
載體標簽: | -- |
載體抗性: | Zeocin |
篩選標記: | 無 |
克隆菌株: | DH5α,TOP10 等 |
宿主細胞: | 常規細胞系(293、CHO等) |
備注: |
pFUSE-hIgG1e2-Fc2載體說明書 pFUSE-hIgG1e2-Fc2載體序列 |
產品目錄號: | 21756894 |
穩定性: | 瞬表達 |
組成型/誘導型: | 組成型 |
病毒/非病毒: | 非病毒 |
買家導航
pFUSE-hIgG1e2-Fc2載體質粒基本信息
pFUSE-hIgG1e2-Fc2質粒圖譜載體圖譜和pFUSE-hIgG1e2-Fc2載體序列質粒序列多克隆位點信息
pFUSE-hIgG1e2-Fc2質粒載體簡介
pFUSE-hIgG1e2-Fc2質粒序列載體序列
pFUSE-hIgG1e2-Fc2 Snapgene格式序列 pFUSE-hIgG1e2-Fc2 .gb格式序列
LOCUS pFUSE-hIgG1e2-Fc2 4194 bp DNA circular SYN 31-JUL-2025 DEFINITION . ACCESSION . VERSION . KEYWORDS . SOURCE synthetic DNA construct ORGANISM synthetic DNA construct REFERENCE 1 (bases 1 to 4194) AUTHORS DotmaticsRD TITLE Direct Submission JOURNAL Exported Jul 31, 2025 from SnapGene 8.1.0 //gt12365.cn FEATURES Location/Qualifiers source 1..4194 /mol_type="other DNA" /organism="synthetic DNA construct" promoter 31..242 /label=EF-1-alpha core promoter /note="core promoter for human elongation factor EF-1-alpha" /note="color: #ffffff; direction: RIGHT" LTR 255..523 /label=5' LTR (truncated) /note="truncated 5' long terminal repeat (LTR) from human T-cell leukemia virus (HTLV) type 1" /note="color: #ffe4c4" sig_peptide 573..632 /codon_start=1 /product="human interleukin-2 signal sequence" /label=IL-2 signal sequence /note="color: #993366 Cleavage site after base 632" /translation="MYRMQLLSCIALSLALVTNS" polyA_signal 1359..1480 /label=SV40 poly(A) signal /note="SV40 polyadenylation signal" /note="color: #a6acb3" polyA_signal 1584..1978 /label=beta-globin poly(A) /note="human beta-globin polyadenylation signal" /note="color: #a6acb3" CDS complement(1992..2366) /codon_start=1 /gene="Sh ble from Streptoalloteichus hindustanus" /product="antibiotic-binding protein" /label=BleoR /note="confers resistance to bleomycin, phleomycin, and Zeocin(TM)" /note="color: #ccffcc" /translation="MAKLTSAVPVLTARDVAGAVEFWTDRLGFSRDFVEDDFAGVVRDD VTLFISAVQDQVVPDNTLAWVWVRGLDELYAEWSEVVSTNFRDASGPAMTEIGEQPWGR EFALRDPAGNCVHFVAEEQD" enhancer 2959..3262 /label=CMV enhancer /note="human cytomegalovirus immediate early enhancer" /note="color: #ffffff" rep_origin complement(3342..3930) /direction=LEFT /label=ori /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of replication" /note="color: #ffff00" polyA_signal 4038..4086 /note="synthetic polyadenylation signal" /note="color: #a6acb3" misc_feature 4097..4188 /label=pause site /note="RNA polymerase II transcriptional pause signal from the human alpha-2 globin gene" /note="color: #a6acb3" ORIGIN 1 ggatctgcga tcgctccggt gcccgtcagt gggcagagcg cacatcgccc acagtccccg 61 agaagttggg gggaggggtc ggcaattgaa cgggtgccta gagaaggtgg cgcggggtaa 121 actgggaaag tgatgtcgtg tactggctcc gcctttttcc cgagggtggg ggagaaccgt 181 atataagtgc agtagtcgcc gtgaacgttc tttttcgcaa cgggtttgcc gccagaacac 241 agctgaagct tcgaggggct cgcatctctc cttcacgcgc ccgccgccct acctgaggcc 301 gccatccacg ccggttgagt cgcgttctgc cgcctcccgc ctgtggtgcc tcctgaactg 361 cgtccgccgt ctaggtaagt ttaaagctca ggtcgagacc gggcctttgt ccggcgctcc 421 cttggagcct acctagactc agccggctct ccacgctttg cctgaccctg cttgctcaac 481 tctacgtctt tgtttcgttt tctgttctgc gccgttacag atccaagctg tgaccggcgc 541 ctacctgaga tcaccggcga aggagggcca ccatgtacag gatgcaactc ctgtcttgca 601 ttgcactaag tcttgcactt gtcacgaatt cgatatcggc catggttaga tctgacaaaa 661 ctcacacatg cccaccgtgc ccagcacctg aactcctggg gggaccgtca gtcttcctct 721 tccccccaaa acccaaggac accctctaca tcacccggga acctgaggtc acatgcgtgg 781 tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg gacggcgtgg 841 aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg taccgtgtgg 901 tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac aagtgcaagg 961 tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc aaagggcagc 1021 cccgagaacc acaggtgtac accctgcccc catcccggga ggagatgacc aagaaccagg 1081 tcagcctgac ctgcctggtc aaaggcttct atcccagcga catcgccgtg gagtgggaga 1141 gcaatgggca gccggagaac aactacaaga ccacgcctcc cgtgctggac tccgacggct 1201 ccttcttcct ctacagcaag ctcaccgtgg acaagagcag gtggcagcag gggaacgtct 1261 tctcatgctc cgtgatgcat gaggctctga agttccacta cacgcagaag agcctctccc 1321 tgtctccggg taaatgagtg ctagctggcc agacatgata agatacattg atgagtttgg 1381 acaaaccaca actagaatgc agtgaaaaaa atgctttatt tgtgaaattt gtgatgctat 1441 tgctttattt gtaaccatta taagctgcaa taaacaagtt aacaacaaca attgcattca 1501 ttttatgttt caggttcagg gggaggtgtg ggaggttttt taaagcaagt aaaacctcta 1561 caaatgtggt atggaattaa ttctaaaata cagcatagca aaactttaac ctccaaatca 1621 agcctctact tgaatccttt tctgagggat gaataaggca taggcatcag gggctgttgc 1681 caatgtgcat tagctgtttg cagcctcacc ttctttcatg gagtttaaga tatagtgtat 1741 tttcccaagg tttgaactag ctcttcattt ctttatgttt taaatgcact gacctcccac 1801 attccctttt tagtaaaata ttcagaaata atttaaatac atcattgcaa tgaaaataaa 1861 tgttttttat taggcagaat ccagatgctc aaggcccttc ataatatccc ccagtttagt 1921 agttggactt agggaacaaa ggaaccttta atagaaattg gacagcaaga aagcgagctt 1981 ctagcttatc ctcagtcctg ctcctctgcc acaaagtgca cgcagttgcc ggccgggtcg 2041 cgcagggcga actcccgccc ccacggctgc tcgccgatct cggtcatggc cggcccggag 2101 gcgtcccgga agttcgtgga cacgacctcc gaccactcgg cgtacagctc gtccaggccg 2161 cgcacccaca cccaggccag ggtgttgtcc ggcaccacct ggtcctggac cgcgctgatg 2221 aacagggtca cgtcgtcccg gaccacaccg gcgaagtcgt cctccacgaa gtcccgggag 2281 aacccgagcc ggtcggtcca gaactcgacc gctccggcga cgtcgcgcgc ggtgagcacc 2341 ggaacggcac tggtcaactt ggccatgatg gctcctcctg tcaggagagg aaagagaaga 2401 aggttagtac aattgctata gtgagttgta ttatactatg cagatatact atgccaatga 2461 ttaattgtca aactagggct gcagggttca tagtgccact tttcctgcac tgccccatct 2521 cctgcccacc ctttcccagg catagacagt cagtgactta ccaaactcac aggagggaga 2581 aggcagaagc ttgagacaga cccgcgggac cgccgaactg cgaggggacg tggctagggc 2641 ggcttctttt atggtgcgcc ggccctcgga ggcagggcgc tcggggaggc ctagcggcca 2701 atctgcggtg gcaggaggcg gggccgaagg ccgtgcctga ccaatccgga gcacatagga 2761 gtctcagccc cccgccccaa agcaagggga agtcacgcgc ctgtagcgcc agcgtgttgt 2821 gaaatggggg cttggggggg ttggggccct gactagtcaa aacaaactcc cattgacgtc 2881 aatggggtgg agacttggaa atccccgtga gtcaaaccgc tatccacgcc cattgatgta 2941 ctgccaaaac cgcatcatca tggtaatagc gatgactaat acgtagatgt actgccaagt 3001 aggaaagtcc cataaggtca tgtactgggc ataatgccag gcgggccatt taccgtcatt 3061 gacgtcaata gggggcgtac ttggcatatg atacacttga tgtactgcca agtgggcagt 3121 ttaccgtaaa tactccaccc attgacgtca atggaaagtc cctattggcg ttactatggg 3181 aacatacgtc attattgacg tcaatgggcg ggggtcgttg ggcggtcagc caggcgggcc 3241 atttaccgta agttatgtaa cgcctgcagg ttaattaaga acatgtgagc aaaaggccag 3301 caaaaggcca ggaaccgtaa aaaggccgcg ttgctggcgt ttttccatag gctccgcccc 3361 cctgacgagc atcacaaaaa tcgacgctca agtcagaggt ggcgaaaccc gacaggacta 3421 taaagatacc aggcgtttcc ccctggaagc tccctcgtgc gctctcctgt tccgaccctg 3481 ccgcttaccg gatacctgtc cgcctttctc ccttcgggaa gcgtggcgct ttctcatagc 3541 tcacgctgta ggtatctcag ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac 3601 gaaccccccg ttcagcccga ccgctgcgcc ttatccggta actatcgtct tgagtccaac 3661 ccggtaagac acgacttatc gccactggca gcagccactg gtaacaggat tagcagagcg 3721 aggtatgtag gcggtgctac agagttcttg aagtggtggc ctaactacgg ctacactaga 3781 agaacagtat ttggtatctg cgctctgctg aagccagtta ccttcggaaa aagagttggt 3841 agctcttgat ccggcaaaca aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag 3901 cagattacgc gcagaaaaaa aggatctcaa gaagatcctt tgatcttttc tacggggtct 3961 gacgctcagt ggaacgaaaa ctcacgttaa gggattttgg tcatggctag ttaattaaca 4021 tttaaatcag cggccgcaat aaaatatctt tattttcatt acatctgtgt gttggttttt 4081 tgtgtgaatc gtaactaaca tacgctctcc atcaaaacaa aacgaaacaa aacaaactag 4141 caaaataggc tgtccccagt gcaagtgcag gtgccagaac atttctctat cgaa //
pFUSE-hIgG1e2-Fc2載體圖譜質粒圖譜pdf版和pFUSE-hIgG1e2-Fc2載體序列質粒序列等相關資料下載
pFUSE-hIgG1e2-Fc2質粒載體應用舉例
- 上一篇:pEF1α-Tet3G
- 下一篇:pFUSE-hIgG1e2-Fc1